Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-007129
Filing Date
2023-03-09
Accepted
2023-03-09 16:16:15
Documents
114
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2357008
2 ex10-07.htm EX-10.07 114827
3 ex10-21.htm EX-10.21 127577
4 ex21-1.htm EX-21.1 3452
5 ex23-1.htm EX-23.1 3967
6 ex31-1.htm EX-31.1 18424
7 ex31-2.htm EX-31.2 11649
8 ex32-1.htm EX-32.1 10397
9 form10-k_001.jpg GRAPHIC 246176
10 form10-k_002.jpg GRAPHIC 235470
11 form10-k_003.jpg GRAPHIC 52484
12 form10-k_004.jpg GRAPHIC 50298
13 form10-k_005.jpg GRAPHIC 32807
14 form10-k_006.jpg GRAPHIC 16729
15 form10-k_007.jpg GRAPHIC 249526
  Complete submission text file 0001493152-23-007129.txt   12075398

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE lctx-20221231.xsd EX-101.SCH 79503
17 XBRL CALCULATION FILE lctx-20221231_cal.xml EX-101.CAL 87671
18 XBRL DEFINITION FILE lctx-20221231_def.xml EX-101.DEF 303974
19 XBRL LABEL FILE lctx-20221231_lab.xml EX-101.LAB 568475
20 XBRL PRESENTATION FILE lctx-20221231_pre.xml EX-101.PRE 453327
108 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1328913
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12830 | Film No.: 23719952
SIC: 2836 Biological Products, (No Diagnostic Substances)